ArticleBiomaterials2026
Coupling intraoperative bioprinting and surgical micropuncture for synergistic scaffold vascularization.
Article in Biomaterials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Three-Dimensional Bioprinting in Reconstructive Plastic Surgery: A Comprehensive Review.Cells · 2026Review
- Optimization of Bioink Formulations and Bioprinting Conditions for Enhanced Cell Viability in Particle-Containing Constructs.Polymers · 2026Article
- Three-tier framework for high-throughput biofabrication: Integrating 3D bioprinting, assistive platforms, and translational opportunities.Bioactive materials · 2026Review
- 3D bioprinting of cell-laden constructs: technologies, bioink design, and biomedical applications.Biomedical materials (Bristol, England) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Intraoperative bioprinting (IOB) is an advanced approach enabling the reconstruction of tissue defects by precisely bioprinting biologics under surgical settings. However, IOB has limited translational potential in its current form secondary to difficulty in establishing a rapidly functional, anastomosed vascular network. Micropuncture (MP) is an innovative microsurgical approach that overcomes this obstacle by creating targeted perforations in the host macrovasculature to stimulate angiogenesis, thereby facilitating microvascular ingrowth into adjacent bioprinted constructs. This study presents the first attempt of MP-induced vascularization of intraoperatively bioprinted constructs (10 mm × 15 mm × 3 mm). After precise optimization of bioink and cell compositions, IOB was performed in rat hindlimbs using rat aortic endothelial cell (RAOEC)-laden bioink to synergistically promote vascularization in conjugation with MP. The combination of MP and RAOECs demonstrated the highest values across all parameters such as a 1.8-fold vessel density increase, 2-fold increase in vessel length, a 2.5-fold increase in PECAM-1 expression, and a 4.2-fold increase in F4/80 expression on Day 40 compared to the bioink-only group. Additionally, perfusion was observed in bioprinted constructs, confirming functional microvascular anastomoses to the host. Taken together, the present study proposes an advanced pre-clinical strategy that integrates IOB for customized bioprinted platforms with MP to rapidly achieve effective in-situ vascularization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.